Phase III clinical data from SCENESSE trials (the FDA-approved formulation of afamelanotide) demonstrated that patients with erythropoietic protoporphyria achieved clinically meaningful photoprotection after 60 days of sustained drug delivery via controlled-release implant
For patients on approved GLP-1 therapies, suspected adverse effects can also be reported via the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk
The most common side effects are nausea (~15%), diarrhea (~15%), and other gastrointestinal complaints
Kojic Acid Mechanism Kojic acid works externally by: Inhibiting the enzyme tyrosinase, which is responsible for melanin production Reducing the formation of excess pigment on the skins surface Its action is localised and cosmetic, meaning results depend on consistent topical use and skin tolerance
Western blot For whole-pancreas lysates, complete pancreatic tissue was homogenized in 1.5 ml of hypotonic lysis buffer as previously described for cardiac tissue [93] using metal beads in a Tissue Lyser (Qiagen) with two 2-min pulses of 1/30 s speed